Aquestive Therapeutics Stock Price - AQST

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.30 5.55% 5.71 5.87 5.41 5.47 5.41 14:56:36
Bid Price Ask Price Spread Spread % News
5.66 5.74 0.08 1.39% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,576 273,912 $ 5.67 $ 1,553,964 206,383 2.95 - 18.0653
Last Trade Time Type Quantity Stock Price Currency
14:56:40 8 $ 5.67 USD

Aquestive Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 144.75M 25.04M $ -61.38M -2.47 - 22.66M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 18.00 9.50%

more financials information »

Aquestive Therapeutics News

Loading Messages....

Latest AQST Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQST Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.186.405.27025.75282,385-0.47-7.61%
1 Month3.236.64993.035.01281,8182.4876.78%
3 Months4.046.64992.954.34161,1531.6741.34%
6 Months5.076.64992.954.25136,0830.6412.62%
1 Year16.6518.06532.955.63129,811-10.94-65.71%
3 Years15.0520.69612.958.68136,808-9.34-62.06%
5 Years15.0520.69612.958.68136,808-9.34-62.06%

Aquestive Therapeutics Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, and Zuplenz. The products pipeline includes Exservan Oral Film, Libervant Buccal Film, AQST-119, AQST-108, and AQST-305.


Your Recent History
NASDAQ
AQST
Aquestive ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.